Primo N. Lara

Docetaxel and Estramustine Compared with Mitoxantrone and Prednisone for Advanced Refractory Prostate Cancer

Daniel P. Petrylak, Catherine M. Tangen, Maha Hussain et al. · New England Journal of Medicine · 2004 · 3.7K citations · Full text

Pharmacy, Oncology, Pharmacotherapy +13

Genomic Hallmarks and Structural Variation in Metastatic Prostate Cancer

David A. Quigley, Ha X. Dang, Shuang G. Zhao et al. · Cell · 2018 · 748 citations · Full text

Medicine, Genetics, Molecular Genetics +16

Kidney Cancer, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology

Robert J. Motzer, Eric Jonasch, Neeraj Agarwal et al. · Journal of the National Comprehensive Cancer Network · 2022 · 655 citations · Full text

Medicine, Oncology, Surgery +17

Prospective Evaluation of Cancer Clinical Trial Accrual Patterns: Identifying Potential Barriers to Enrollment

Primo N. Lara, Roger Higdon, Nelson Lim et al. · Journal of Clinical Oncology · 2001 · 603 citations

Medicine, Oncology, Cancer Control +13

Phase III Trial of Irinotecan/Cisplatin Compared With Etoposide/Cisplatin in Extensive-Stage Small-Cell Lung Cancer: Clinical and Pharmacogenomic Results From SWOG S0124

Primo N. Lara, Ronald B. Natale, John Crowley et al. · Journal of Clinical Oncology · 2009 · 521 citations · Full text

Medicine, Oncology, Pharmacology +16